Evidence map›Paper›PMID 25231976›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2014

MicroRNA-155 potentiates the inflammatory response in hypothermia by suppressing IL-10 production.

Adrian T Billeter, Jason Hellmann, Henry Roberts, Devin Druen, Sarah A Gardner, Harshini Sarojini, Susan Galandiuk, Sufan Chien, Aruni Bhatnagar, Matthew Spite and 1 more

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. New insights ofWorld journal of clinical cases · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Adrian T BilleterPrice Institute of Surgical Research, Hiram C. Polk, Jr., M.D. Department of Surgery, and adrianbilleter@bluewin.ch.
Jason HellmannDiabetes and Obesity Center, Institute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Henry RobertsPrice Institute of Surgical Research, Hiram C. Polk, Jr., M.D. Department of Surgery, and.
Devin DruenPrice Institute of Surgical Research, Hiram C. Polk, Jr., M.D. Department of Surgery, and.
Sarah A GardnerPrice Institute of Surgical Research, Hiram C. Polk, Jr., M.D. Department of Surgery, and.
Harshini SarojiniPrice Institute of Surgical Research, Hiram C. Polk, Jr., M.D. Department of Surgery, and.
Susan GalandiukPrice Institute of Surgical Research, Hiram C. Polk, Jr., M.D. Department of Surgery, and.
Sufan ChienPrice Institute of Surgical Research, Hiram C. Polk, Jr., M.D. Department of Surgery, and.
Aruni BhatnagarDiabetes and Obesity Center, Institute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Matthew SpiteDiabetes and Obesity Center, Institute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, Kentucky, USA mspite@partners.org.
Hiram C PolkPrice Institute of Surgical Research, Hiram C. Polk, Jr., M.D. Department of Surgery, and.
University of Louisville · USRice Institute · US

Funding

Project 5 - Metabolomic Analysis of AtherothrombosisP20GM103492 · NIGMS · UNIVERSITY OF LOUISVILLE · PI DEFILIPPIS, ANDREW · 2012 to 2017
$13.8M
Role of Inflammation-Resolving Lipid Mediators In Ischemic RevascularizationR01HL106173 · NHLBI · UNIVERSITY OF LOUISVILLE · PI SPITE, MATTHEW R · 2011 to 2023
$5.7M
Nutrient excess alters resolution of inflammation in diabetes and obesityF32HL116186 · NHLBI · UNIVERSITY OF LOUISVILLE · PI HELLMANN, JASON L · 2013 to 2015
$159k
NHLBI NIH HHS F32 HL116186NHLBI NIH HHS HL-106173NHLBI NIH HHS HL-116186NHLBI NIH HHS R01 HL106173NIGMS NIH HHS GM-103492NIGMS NIH HHS P20 GM103492
6 · The paper itself

Abstract

Therapeutic hypothermia is commonly used to improve neurological outcomes in patients after cardiac arrest. However, therapeutic hypothermia increases sepsis risk and unintentional hypothermia in surgical patients increases infectious complications. Nonetheless, the molecular mechanisms by which hypothermia dysregulates innate immunity are incompletely understood. We found that exposure of human monocytes to cold (32°C) potentiated LPS-induced production of TNF and IL-6, while blunting IL-10 production. This dysregulation was associated with increased expression of microRNA-155 (miR-155), which potentiates Toll-like receptor (TLR) signaling by negatively regulating Ship1 and Socs1. Indeed, Ship1 and Socs1 were suppressed at 32°C and miR-155 antagomirs increased Ship1 and Socs1 and reversed the alterations in cytokine production in cold-exposed monocytes. In contrast, miR-155 mimics phenocopied the effects of cold exposure, reducing Ship1 and Socs1 and altering TNF and IL-10 production. In a murine model of LPS-induced peritonitis, cold exposure potentiated hypothermia and decreased survival (10 vs. 50%; P < 0.05), effects that were associated with increased miR-155, suppression of Ship1 and Socs1, and alterations in TNF and IL-10. Importantly, miR-155-deficiency reduced hypothermia and improved survival (78 vs. 32%, P < 0.05), which was associated with increased Ship1, Socs1, and IL-10. These results establish a causal role of miR-155 in the dysregulation of the inflammatory response to hypothermia.

Indexed as

AnimalsCells, CulturedCytokinesHumansHypothermiaInflammationInterleukin-10MiceMicroRNAsMonocytesSignal TransductionToll-Like ReceptorsCytokinesInterleukin-10MicroRNAsMIRN155 microRNA, humanToll-Like Receptorscold exposureperitonitissepsis

Identifiers

PMID25231976
PMCPMC4232280
OpenAlexW2011944093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.